期刊文献+

血清趋化因子CCL19和CCL21水平变化在慢性阻塞性肺疾病中的意义及对肺动脉高压的预测价值 被引量:5

Significance of changes in serum chemokine CCL19 and CCL21 levels in chronic obstructive pulmonary disease and their predictive value for pulmonary hypertension
下载PDF
导出
摘要 目的探讨血清趋化因子CCL19和CCL21水平变化在慢性阻塞性肺疾病中的意义及对肺动脉高压的预测价值。方法选择于我院住院治疗的慢性阻塞性肺疾病患者150例,根据肺动脉压是否正常分为肺动脉压增高组(68例)和肺动脉压正常组(82例),并选取健康体检者60例作为对照组。比较各组血清趋化因子CCL19和CCL21水平的差异。应用logistics回归模型分析影响慢性阻塞性肺疾病患者发生肺动脉高压的危险因素。应用受试者工作(ROC)曲线评价CCL19和CCL21水平对肺动脉高压的诊断价值。结果 CCL19和CCL21水平在对照组、肺动脉压正常组、肺动脉压增高组间逐渐升高,差异均有统计学意义(P<0.05)。单因素和多因素回归分析显示:CCL19和CCL21为影响慢性阻塞性肺疾病患者发生肺动脉高压的危险因素(P<0.05); ROC曲线分析显示,CCL19的曲线下面积为0.905,CCL21的曲线下面积为0.937。结论 CCL19和CCL21水平是影响慢阻肺患者发生肺动脉高压的危险因素,并与肺动脉压力呈正相关,可作为预测发生肺动脉高压的参考指标。 Objective To investigate the levels of CCL19 and CCL21 in serum in patients with chronic obstructive pulmonary disease,and to explore their predictive value for pulmonary hypertension.Methods 150 patients with chronic obstructive pulmonary disease hospitalized in our hospital were selected.According to whether the pulmonary artery pressure was normal,all patients were divided into pulmonary artery pressure increasing group(68cases)and pulmonary artery pressure normal group(82cases).60 healthy people were selected as the control group.The differences of the levels of CCL19and CCL21levels in serum were compared in each group.Application of logistic regression model was used to analyze risk factors affecting pulmonary hypertension in patients with chronic obstructive pulmonary disease.The use of receiver operating(ROC)curves was performed to evaluate the diagnostic value of CCL19and CCL21levels in pulmonary arterial hypertension.Results The levels of CCL19and CCL21gradually increased in the control group,the normal pulmonary artery pressure group,and the pulmonary arterial pressure increase group,and the differences were statistically significant(P<0.05).Univariate and multivariate regression analysis showed that CCL19and CCL21were risk factors for pulmonary hypertension in patients with chronic obstructive pulmonary disease(P<0.05).ROC curve analysis shows that the area under the curve of CCL19 was 0.905,and the area under the curve of CCL21was 0.937.Conclusion CCL19and CCL21levels were risk factors for pulmonary hypertension in COPD patients.Both were positively related to pulmonary artery pressure and can be used as references for predicting pulmonary hypertension.
作者 江义霞 李匡政 席云祝 刘青 贾远航 JIANG Yi-xia(Department of respiratory medicine, Second Hospital Affiliated to Nanhua University,Hengyang 421000,China)
出处 《牡丹江医学院学报》 2018年第6期9-12,共4页 Journal of Mudanjiang Medical University
关键词 CCL19 CCL21 慢性阻塞性肺疾病 肺动脉高压 CCL19 CCL21 chronic obstructive pulmonary disease pulmonary hypertension
  • 相关文献

二级参考文献10

  • 1O'KEEFE KL, KILIC A, POPE-HARMAN A, et al. Changes in pulmonary artery pressure affect survival differently in lung transplant recipients who have pulmonary hypertension or chronic obstructive pulmonary disease[J]. Exp Clin Transplant, 2014, 12 (4): 283-289.
  • 2KOSANOVIC D, DAHAL BK, PETERS DM, et al. Histological characterization of mast cell chymase in patients with pulmonary hypertension andchronic obstructive pulmonary disease[J]. Pulm Circ, 2014, 4(1): 128-136.
  • 3MARON BA, GOLDSTEIN RH, ROUNDS SI, et al. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment ofpulmonary hypertension due to chronic ob- structive lung disease: the TADA-PHiLD(TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial[J]. Pulm Circ, 2013, 3(4): 889-897.
  • 4HOFFMANN J, WILHELM J, MARSH LM, et al. Distinct differ- ences in gene expression patterns in pulmonary arteries of pa- tients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension[J]. Am J Respir Crit Care Med, 2014, 190(1): 98-111.
  • 5WROBEL JP, MCLEAN CA, THOMPSON BR, et al. Pulmonary arterial remodeling in chronic obstructive pulmonary disease is lobe deDendent[J]. Pulm Circ, 2013, 3(3): 665-674.
  • 6TAKENAKA S, KAWAYAMA T, IMAOKA H, et al. The pro- gression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model[J]. Biochem Biophys Res Commun, 2014, 445(3): 597-601.
  • 7吴春玲,郭韵,刘海娜,赵丽娟,肖卫国.类风湿关节炎患者外周血淋巴细胞趋化因子受体CCR7的表达及其临床意义[J].中国全科医学,2010,13(30):3358-3360. 被引量:8
  • 8向光明,高宝安,陈世雄,官莉,阮玉姝,张婷婷,赵必君.低氧性肺动脉高压患者肺动脉收缩压与MMP-2、TIMP-1和炎性因子的相关性研究[J].实用医学杂志,2011,27(22):4046-4048. 被引量:6
  • 9马航,何海艳,邱海艳,陶一江.慢性阻塞性肺疾病合并肺高压患者血清及呼出气冷凝液中炎症因子变化及意义[J].南京医科大学学报(自然科学版),2013,33(1):97-101. 被引量:7
  • 10吴志红,谢沛霖,周大平.类风湿关节炎并间质性肺炎16例临床分析[J].中国免疫学杂志,2013,29(10):1059-1060. 被引量:11

共引文献32

同被引文献50

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部